Hepatitis Treatment News
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis Treatment News


March 25, 2015
Harvoni Is Mostly Cost Effective, But Budget Impact Will Be Huge
In most cases, Harvoni is cost effective when compared with older hepatitis C treatments, but treating all of those in need will be highly expensive.
March 23, 2015
Sovaldi or Harvoni and Heart Med Cordarone Can Be a Fatal Mix
Nine people taking Harvoni or Sovaldi and the heart medication Cordarone (amiodarone) have suffered from low heartbeats; one died of a heart attack.
March 18, 2015
World Health Organization Issues Hepatitis B Guidelines
The World Health Organization has issued its first hepatitis B guidelines, geared in particular toward simplifying treatment and care for those in limited-resource settings.
March 12, 2015
BMS Resubmits FDA Application for Hepatitis C Drug Daclatasvir
BMS has resubmitted an application to the FDA for approval of daclatasvir, this time in combination with Sovaldi (sofosbuvir), to treat genotype 3 of hepatitis C.
March 11, 2015
High Rates of Advanced Liver Damage in Hep C-Diagnosed Boomers
Baby boomers have high rates of advanced liver fibrosis and cirrhosis, aidsmap reports.
March 09, 2015
Pricey New Hep C Drugs Still Cheaper Per Cure Than Oldest Ones
While highly expensive, treating hepatitis C  with the combination of Sovaldi and Olysio is still cheaper per cure than treating with interferon and ribavirin.
March 05, 2015
Delaying Hep C Therapy for HIV/HCV Coinfected People Is Risky
For those coinfected with HIV, waiting to begin hepatitis C treatment until liver damage progresses raises the risk of liver-related complications and death.
March 04, 2015
Coinfected People With Hep C May Have to Switch HIV Meds to Take Olysio
People who coinfected with HIV and hepatitis C  looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug interactions.
March 03, 2015
96% Hep C Cure Rate for Harvoni in Those Coinfected With HIV
Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.
March 02, 2015
WHO Calls for Universal Use of 'Smart Syringes' by 2020
The World Health Organization has called for all hospitals and clinics worldwide to use “smart syringes,” which prevent a second use, by 2020.
Archives
   

March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
January 2008


QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Do you know anyone living with hepatitis B?
Yes
No


Survey
Hepatitis C Reader Survey
HEP ON TWITTER
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.